SUBSCRIBE
SUBSCRIBE
Pharm Country

Sun Pharmaceutical Industries Ltd to Sell Some Merck & Co., Inc. Diabetes Drugs in India

April 25, 2011 | 
1 min read

(Reuters) - Sun Pharmaceutical Industries Ltd has entered into a deal to market Merck’s diabetes drugs -- sitagliptin and sitagliptin plus metformin -- in India, the two drugmakers said in a statement on Monday.

Asia
Merck & Co.
MORE ON THIS TOPIC
Signage at Pfizer's world headquarters in New York City
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
March 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Facade of AstraZeneca's office in Shanghai, China
Mergers & acquisitions
AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue
February 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration
Mergers & acquisitions
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
February 10, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Rare diseases
AceLink’s Fabry Hopeful Shows Potential in Mid-Stage Study
February 10, 2025
 · 
2 min read
 · 
Tristan Manalac